EN
HI
Kabra Drugs Share price
KABRADG
31.57
1.03 (-3.16%)Last updated on 23 Feb, 2026 | 15:51 IST
BUYSELL
Today's High
33.40
Today's Low
31.20
52 Week Low
10.56
52 Week High
35.52
Free Demat with Zero AMC*
Kabra Drugs Chart
Kabra Drugs Share Key Metrics
Volume
46749.00
Market Cap
74.85 CR
LTQ@LTP
31@31.57
ATP
31.93
Var Margin
100 %
Circuit Range
30.97-34.23
Delivery %
0 %
Value
14.93 L
ASM/GSM
No
Market Lot
1
Summary
At 23 Feb, 2026 | 15:51, Kabra Drugs share price stands at ₹31.57, showing a 1.03% -3.16 for the day. The stock’s intraday movement has stayed between ₹31.20 and ₹33.40, while on a 52-week basis it has fluctuated from ₹10.56 to ₹35.52.
In terms of trading activity, Kabra Drugs has recorded a volume of 46749 shares, with a market capitalisation of ₹23707850. The stock’s Average Traded Price (ATP) stands at ₹3193, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 31,3157. The stock operates within a circuit range of ₹30.97-34.23, with a Value of ₹14.93 L. The Delivery Percentage for the day is %. Additionally, Kabra Drugs currently falls under the No framework, and trades with a market lot size of 1.
Kabra Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
63.23
Sector P/B
2.76
Sec. Div. Yield
0.57
Kabra Drugs Resistance and Support
Pivot 32.74
Resistance
First Resistance
33.66
Second Resistance
34.72
Third Resistance
35.64
Support
First Support
31.68
Second Support
30.76
Third Support
29.7
Kabra Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-13 | Quarterly Results |
| 2025-11-28 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-10-08 | Others |
| 2025-09-02 | Others |
| 2025-08-14 | Quarterly Results |
| 2025-08-06 | Others |
| 2025-06-18 | Others |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
Kabra Drugs News
About Kabra Drugs
NSE : 0
BSE : 524322
ISIN : INE323K01017
Kabra Drugs Management
| Name | Position |
|---|---|
| Mr. N Aravind | Managing Director |
| Mr. Bangalore Venkatakrishnappa Ananth Kumar | WholeTime Director & CFO |
Kabra Drugs Similar Stocks
Ortin Global Ltd.
18.12
-0.95 (4.98%)
Starsource Multitrade Ltd.
94.20
-4.80 (4.85%)
Unjha Formulations Ltd.
22.00
-0.50 (2.22%)
Hindustan Bio Sciences Ltd.
8.33
0.39 (4.91%)
Gian Life Care Ltd.
8.71
-0.45 (4.91%)
Dhanvantri Jeevan Rekha Ltd.
26.50
0.64 (2.47%)
Decipher Labs Ltd.
8.00
-0.49 (5.77%)
Dr Lalchandani Labs Ltd.
16.71
0.00 (0.00%)
Transpact Enterprises Ltd.
166.65
7.90 (4.98%)
MPS Pharmaa Ltd.
1.76
0.00 (0.00%)
Kabra Drugs FAQs
The Buying Price of Kabra Drugs share is 31.57 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kabra Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kabra Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 63.23 & 2.76 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kabra Drugs is 74.85 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kabra Drugs share price is 35.52 & 10.56. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kabra Drugs belongs to the Healthcare sector.
